Clinical Trial Update: Interaction Between Magnesium and Neostigmine or Sugammadex for the Reversal of a Rocuronium-induced Neuromuscular Block [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the interaction between magnesium and reversal agents neostigmine or sugammadex for rocuronium-induced neuromuscular block.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuromuscular Blockade

Drugs mentioned

• Magnesium (magnesium)
• Neostigmine (neostigmine)
• Rocuronium (rocuronium bromide)
• Sugammadex (sugammadex)

Snippet

Sponsor: Christoph Czarnetzki | Conditions: Neuromuscular Blockade | Phase 4 | Status: COMPLETED